drugset / Trial / NCT07016074
Inorganic Nitrate (NaNO3) Prevention of Contrast-Associated Acute Kidney Injury
RandomizedParallel-groupQuadruple-blindPrevention
Summary
This pilot study is designed to test the logistics and recruitment of a trial testing the benefit of sodium nitrate in the prevention of contrast-associated kidney injury in a group of patients at high-risk.
Timeline
- Start
- 2025-06-30
- Primary completion
- 2026-07
- Completion
- 2026-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sodium Nitrate | Other / unclassified | 12 mmol | Oral |